 |
International
Expert Committee Report on the Role of the A1C Assay in the Diagnosis
of Diabetes |
| |
The International Expert Committee hopes that
its report will serve as a stimulus to the international community
and professional organizations to consider the use of the A1C assay
for the diagnosis of diabetes (Diabetes Care) |
| |
|
|
2009
Annual Evidence Update - Obesity |
| |
Childhood obesity: surveillance and prevention
(NHS Evidence) |
| |
|
|
HIV
infection alone does not increase risk of diabetes |
| |
people with HIV had a lower risk of diabetes
than HIV-negative individuals (Aidsmap) |
| |
|
|
New
theory for global diabetes epidemic |
| |
A new "fertility first" hypothesis
published this week by a group of international experts in the
American Journal of Human Biology, proposes that the global epidemic
of Type 2 diabetes has its origins in the struggle, over millennia,
to sustain human fertility in environments defined by famine (University
of Sydney) |
| |
|
|
Diabetes
and acute coronary syndromes |
| |
Despite the benefit, multiple surveys have demonstrated
that, in the setting of ACS, diabetic patients receive evidence-based
therapy less frequently than non-diabetic counterparts (Best Practice & Research Clinical Endocrinology & Metabolism) |
| |
|
|
Impact
of Glycemic Treatment Choices on Cardiovascular Complications
in Type 2 Diabetes |
| |
Although past epidemiological studies have shown
a relationship between glycated hemoglobin levels and CV events
in patients with type 2 diabetes, recent large randomized clinical
trials (ACCORD, ADVANCE, and VADT) lasting 3.5 to 5.6 years have
found that intensive glycemic control either has no impact on CV
outcomes or even worsens them (Cardiology in Review) |
| |
|
|
Access
Pharmaceuticals Announces Initiation of Two New Cobalamin™ Oral Insulin Drug Delivery Collaborations |
| |
Cobalamin oral insulin and oral human growth
hormone formulations provide significant pharmacological responses
(Access Pharmaceuticals) |
| |
|
|
Research
by Hebrew University scientist holds promise for novel oral anti-diabetic
drugs |
| |
Promise is held out for the development of novel
oral drugs to control blood glucose levels in diabetes patients
as the result of research by a scientist at the (Hebrew University
of Jerusalem) |
| |
|
|
Melatonin
receptors in pancreatic islets: good morning to a novel type
2 diabetes gene |
| |
Individuals may be more sensitive to the actions
of melatonin, leading to impaired insulin secretion. Blocking the
inhibition of insulin secretion by melatonin may be a novel therapeutic
avenue for type 2 diabetes (Diabetologia) |
| |
|
